BioCentury
ARTICLE | Finance

Expansion capital

Insights into the sweet spot of private equity firm GHO

November 2, 2015 8:00 AM UTC

GHO Capital expects the common thread among its private equity deals will be healthcare companies that want to grow a nascent revenue stream by geographic expansion in Europe.

The firm plans to make eight or nine investments over the life of its first fund, which had an undisclosed first close this summer. Its first deal was the €104 million ($118.4 million) purchase of DNA Diagnostics Center Inc. on Oct. 13. ...